Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)

NCT03400033 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

407

Enrollment

INDUSTRY

Sponsor class

Conditions

Anaemia

Interventions

DRUG: Daprodustat tablets
DRUG: Matching placebo tablets
DRUG: Epoetin alfa vials
DRUG: Saline vials or bags

Sponsor

GlaxoSmithKline